SARS-CoV-2 causes viral pneumonia. The initial symptoms of patients are mostly fever, dry cough, and severe symptoms such as the gradual appearance of dysnea. Most patients have a good prognosis, and some severe cases may develop acute respiratory distress syndrome or septic shock, or even death. We have carried out a series of product development for different groups (suspected patients, recovered patients, and vaccinated healthy people) and at different stages (initial infection, infection period, recovery period, and after vaccination).
SARS-CoV-2 IVD covers the detection of SARS-CoV-2 antigen, SARS-CoV-2 IgG / IgM antibody, and SARS-CoV-2 neutralizing antibody. The principle of lateral-flow immunochromatography is applied, the test kit can be used for rapid, convenient and accurate detection.
SARS-CoV-2 Antigen Rapid Test Kit
SARS-CoV-2 Antigen Rapid Test Kit is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs, nasopharyngeal swabs and saliva. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.
Easier: No special equipment needed; Easy to use; Intuitive visual interpretation.
Rapid: Results in 10-15 minutes.
Accurate: Results were validated by PCR and Clinical diagnosis.
Diversity: Works with oropharyngeal swab, nasal swab, nasopharyngeal swab and saliva.
Neutralization antibody is the most important marker of possible immunity. Anti-SARS-CoV-2 Neutralization Antibody Test Kit is used to determine whether the body has obtained immunity after vaccine injection, whether the individual that recovered from clinical treatment has potential immunity, and the lifetime of neutralizing antibodies in human body.
Anti-SARS-CoV-2 Neutralization Antibody Test Kit is used for in vitro detection of SARS-CoV-2 neutralizing antibodies in serum, plasma or whole blood.
Procedure is simple and time saving.
Easy to collect samples
Results were validated by Clinical diagnosis.
Suitable for High-throughput screening.
Kits for SARS-CoV-2 Neutralization antibody detection：
COVID-19 IgG/IgM Rapid Test (Serum/Plasma/Whole Blood) is a rapid chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to COVID-19 in human serum, plasma or whole blood as an aid in the diagnosis of primary and secondary COVID-19 infections.
Easier: No special equipment needed, Intuitive visual interpretation.
Rapid: Quick sampling by fingertip blood, Result in 10 minutes.
Accurate: Results with IgG and IgM respectively, validated using PCR and CT.
Application: For suspicious patients with symptoms, mild symptoms, or even without symptoms, also for testing people with close contact of infected patients and people under quarantine control.